151 related articles for article (PubMed ID: 9074418)
41. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.
Kojima S; Horibe K; Inaba J; Yoshimi A; Takahashi Y; Kudo K; Kato K; Matsuyama T
Br J Haematol; 2000 Oct; 111(1):321-8. PubMed ID: 11091219
[TBL] [Abstract][Full Text] [Related]
42. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group.
Arnold R; de Witte T; van Biezen A; Hermans J; Jacobsen N; Runde V; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1998 Jun; 21(12):1213-6. PubMed ID: 9674854
[TBL] [Abstract][Full Text] [Related]
43. Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic Anemia.
Holmqvist AS; Chen Y; Wu J; Battles K; Francisco L; Hageman L; Kung M; Ness E; Parman M; Winther JF; Rosenthal J; Arora M; Armenian SH; Bhatia S
Biol Blood Marrow Transplant; 2019 Apr; 25(4):749-755. PubMed ID: 30578940
[TBL] [Abstract][Full Text] [Related]
44. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
45. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome.
Davies SM; Shu XO; Blazar BR; Filipovich AH; Kersey JH; Krivit W; McCullough J; Miller WJ; Ramsay NK; Segall M
Blood; 1995 Aug; 86(4):1636-42. PubMed ID: 7632974
[TBL] [Abstract][Full Text] [Related]
46. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
[TBL] [Abstract][Full Text] [Related]
47. Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita.
Langston AA; Sanders JE; Deeg HJ; Crawford SW; Anasetti C; Sullivan KM; Flowers ME; Storb R
Br J Haematol; 1996 Mar; 92(3):758-65. PubMed ID: 8616050
[TBL] [Abstract][Full Text] [Related]
48. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
[TBL] [Abstract][Full Text] [Related]
49. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
50. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group.
Chen J; Lee V; Luo CJ; Chiang AK; Hongeng S; Tan PL; Tan AM; Sanpakit K; Li CF; Lee AC; Chua HC; Okamoto Y
Br J Haematol; 2013 Aug; 162(3):383-91. PubMed ID: 23735201
[TBL] [Abstract][Full Text] [Related]
51. Single institution outcomes of treatment of severe aplastic anaemia.
Mollee P; Woodward N; Durrant S; Lockwood L; Gillett EA; Morton J; Rowell J
Intern Med J; 2001 Aug; 31(6):337-42. PubMed ID: 11529587
[TBL] [Abstract][Full Text] [Related]
52. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors.
Tzeng CH; Chen PM; Fan S; Liu JH; Chiou TJ; Hsieh RK
Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434
[TBL] [Abstract][Full Text] [Related]
53. Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath.
Vassiliou GS; Webb DK; Pamphilon D; Knapper S; Veys PA
Br J Haematol; 2001 Sep; 114(3):701-5. PubMed ID: 11553001
[TBL] [Abstract][Full Text] [Related]
54. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
[TBL] [Abstract][Full Text] [Related]
55. [Second allogenic bone marrow transplantation after late graft rejection in a patient with severe aplastic anemia].
Stamatović D; Balint B; Todorić-Zivanović B; Marjanović S; Lakić-Trajković Z; Malesević M
Vojnosanit Pregl; 2000; 57(5):95-8. PubMed ID: 11213682
[TBL] [Abstract][Full Text] [Related]
56. Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO).
Dini G; Cancedda R; Locatelli F; Bosi A; Bandini G; Alessandrino EP; Porta F; Uderzo C; Messina C; Fagioli F; Arcese W; Marenco P; Fanin R; Falda M; Soligo D; La Nasa G; Giardini C; Pession A; Scimè R; Di Bartolomeo P; Bruno B; Garbarino L; Lamparelli T; Giorgiani G; Lanino E; Manzitti C; Bacigalupo A;
Haematologica; 2001 May; 86(5):451-6. PubMed ID: 11410406
[TBL] [Abstract][Full Text] [Related]
57. Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
Chung IJ; Lee JJ; Park MR; Kook H; Cho SH; Hwang TJ; Kim HJ
J Korean Med Sci; 2002 Aug; 17(4):468-74. PubMed ID: 12172040
[TBL] [Abstract][Full Text] [Related]
58. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint MT; Congiu M; De Planque MM; Ernst P; McCann S
Br J Haematol; 1988 Oct; 70(2):177-82. PubMed ID: 3056497
[TBL] [Abstract][Full Text] [Related]
59. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
60. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.
Bacigalupo A; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint MT; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
Acta Haematol; 2000; 103(1):19-25. PubMed ID: 10705155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
